期刊文献+

小剂量A型肉毒毒素治疗颜面部痉挛的临床分析

Clinical analysis of the therapy of facial spasm by small dose of Botulinum toxin type A
原文传递
导出
摘要 目的探讨小剂量A型肉毒毒素(BTX-A)多点注射治疗颜面部痉挛的临床疗效及安全性。方法回顾性分析BTX-A注射治疗颜面部痉挛患者的资料,评估疗效起止时间、症状缓解程度、不良反应发生率及其严重程度。结果 80例患者接受BTX-A注射治疗。平均起效时间(3.2±1.6)d,达高峰时间(7.2±2.2)d,疗效维持时间(19.6±6.1)周。达到完全缓解50例(62.5%)、明显缓解26例(32.5%)、部分缓解4例(5%)。14例(17.5%)患者出现轻度不良反应。结论小剂量BTX-A多点注射能够明显改善颜面部痉挛患者的症状,不良反应轻。 Objective To investigate the clinical effect and safety of the therapy of facial spasm by small dose of Botulinum toxin type A(BTX-A).Methods The Data of BTX-A injection treatment of facial spasm patients were retrospectively analyzed to evaluate the onset time and duration of the effect,degree of symptom relief,incidence and severity of adverse reaction.Results Eighty patients had been treated with small dose of BTX-A injection.The onset time was(3.2±1.6) days,the peak time of effect was(7.2±2.2) days,the maintain time of efficacy was(19.6±6.1) weeks.Among the 80 patients,50 cases(62.5%) got complete remission,26 cases(32.5%) got apparent remission,and 4 cases(5%) got partial remission.40 cases(17.5%) showed minor adverse reaction.Conclusion Multi-point injection of small dose of BTX-A could significantly improve the facial spasm symptom without causing severe adverse reaction.
出处 《神经病学与神经康复学杂志》 2011年第3期119-121,共3页 Journal of Neurology and Neurorehabilitation
关键词 A型肉毒毒素 眼睑痉挛 面肌痉挛 MEIGE综合征 Botulinum toxin type A blepharo spasm hemifacial spasm Meige's syndrome
  • 相关文献

参考文献10

  • 1庄伟华,彭玉,张其梅,游辉.A型肉毒毒素多点注射治疗面肌及眼睑痉挛的临床分析[J].临床医药实践,2010,19(1X):54-56. 被引量:6
  • 2许波,郭俊,程鹏远.A型肉毒毒素在头痛治疗中的研究进展[J].国际神经病学神经外科学杂志,2007,34(4):330-332. 被引量:5
  • 3曲芳,胡建华,孙英健,单丽华,于萍,宋怡.A型肉毒毒素治疗面肌、眼睑痉挛156例临床观察[J].中风与神经疾病杂志,2003,20(1):68-69. 被引量:7
  • 4万新华,汤晓芙.肉毒毒素及其在神经科疾病的治疗应用[J].中华神经科杂志,1996,29(2):119-122. 被引量:22
  • 5C. Kenney,J. Jankovic.Botulinum toxin in the treatment of blepharospasm and hemifacial spasm[J]. Journal of Neural Transmission . 2008 (4)
  • 6Peter Hambleton.Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use[J]. Journal of Neurology . 1992 (1)
  • 7Frueh,BR,Felt,DP,Wojno,TH,Musch,DC.Treatment of blepharospasm with botulinum toxin: preliminary report. Archives of Ophthalmology . 1984
  • 8Hsiung GY,Das SK,et al.Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Movement Disorders . 2002
  • 9Shorr N,Seiff S R,Kopelman J.The use of botulinum toxin in blepharospasm. American Journal of Ophthalmology . 1985
  • 10Scott AB.Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology . 1980

二级参考文献25

  • 1戴壮,中华眼科杂志,1993年,29卷,144页
  • 2刘增玉,实用眼科杂志,1992年,10卷,646页
  • 3Aurora S. Botulinum toxin type A for the treatment of migraine. Expert Opin Pharmaeother, 2006, 7(8) : 1085-1095.
  • 4Binder WJ, Bfin MF, Blitzer A, et al. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an openlabel study. Otolaryngol Head Neck Surg, 2000, 123 (6) : 669 -676.
  • 5Anand KS, Prasad A, Singh MM, et al. Botulinum toxin type A in prophylactic treatment of migraine. Am J Ther, 2006, 13(3): 183-187.
  • 6Troost BT. Botulinum toxin type A ( Botox ) in the treatment of migraine and other headaches. Expert Rev Neurother, 2004, 4(1) : 27 -31.
  • 7Blumenfeld A. Clinical approaches to migraine prophylaxis. Am J Manag Care, 2005, 11(2 Suppl) : S55-S61.
  • 8Schuhe-Mattler WJ, Martinez-Castrillo JC. Botulinum toxin therapy of migraine and tension-type headache : comparing different botulinum toxin preparations. Eur J Neurol, 2006, 13 (Suppl 1) : 51-54.
  • 9Evers S. Investigating prophylactic botulinum toxin type A for chronic headache disorders. Expert Opin Investig Drugs, 2006, 15(10): 1161-1166.
  • 10Evers S. Status on the use of botulinum toxin for headache disorders. Curr Opin Neurol, 2006, 19(3) : 310-315.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部